Key result
Treatment with a general JNK inhibitor (SP600125) increased fatty acid oxidation and prevented LPS-mediated reduction in fatty acid oxidation and cardiac dysfunction in mice.
Inhibition of the JNK pathway in a murine model of sepsis restores cardiac fatty acid oxidation and prevents heart dysfunction, highlighting a potential mechanism and therapeutic target for sepsis-induced cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for JNK inhibition in sepsis cardiomyopathy; human studies required before any clinical consideration.
Septic shock results from bacterial infection and is associated with multi-organ failure, high mortality, and cardiac dysfunction. Sepsis causes both myocardial inflammation and energy depletion. We hypothesized that reduced cardiac energy production is a primary cause of ventricular dysfunction in sepsis. The JNK pathway is activated in sepsis and has also been implicated in impaired fatty acid oxidation in several tissues. Therefore, we tested whether JNK activation inhibits cardiac fatty acid oxidation and whether blocking JNK would restore fatty acid oxidation during LPS treatment. LPS treatment of C57BL/6 mice and adenovirus-mediated activation of the JNK pathway in cardiomyocytes inhibited peroxisome proliferator-activated receptor α expression and fatty acid oxidation. Surprisingly, none of the adaptive responses that have been described in other types of heart failure, such as increased glucose utilization, reduced αMHC:βMHC ratio or induction of certain microRNAs, occurred in LPS-treated mice. Treatment of C57BL/6 mice with a general JNK inhibitor (SP600125) increased fatty acid oxidation in mice and a cardiomyocyte-derived cell line. JNK inhibition also prevented LPS-mediated reduction in fatty acid oxidation and cardiac dysfunction. Inflammation was not alleviated in LPS-treated mice that received the JNK inhibitor. We conclude that activation of JNK signaling reduces fatty acid oxidation and prevents the peroxisome proliferator-activated receptor α down-regulation that occurs with LPS.
No takes yet. Share an insight, caveat, or question.
Drosatos et al. (2011) studied Septic shock and LPS-induced heart dysfunction. JNK inhibitor (SP600125) vs. LPS treatment alone / Control was evaluated on Cardiac fatty acid oxidation and heart dysfunction. Treatment with a general JNK inhibitor (SP600125) increased fatty acid oxidation and prevented LPS-mediated reduction in fatty acid oxidation and cardiac dysfunction in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: